ARTICLE | Clinical News
Auriclosene: Phase IIb start
December 23, 2013 8:00 AM UTC
Next year, NovaBay said it will begin evaluating an optimized formulation of auriclosene to treat patients with impetigo. In November, NovaBay reported that a topical gel formulation of auriclosene mi...